Do patients with endometrial cancer need reexamination after treatment?

1. First of all, if the treatment of early endometrial cancer is satisfactory, some patients can achieve long-term survival. It is important to note that the factors that affect prognosis are: ① the malignancy of the tumor and the extent of the lesion, including surgical pathological staging, histological type, tumor grade, depth of myometrial invasion, lymph node metastasis and extrauterine metastasis; ② the patient's general condition; ③ the choice of treatment plan, etc. Follow-up of patients with endometrial cancer after treatment. Regular follow-up should be performed after treatment, and 75%~95% of recurrences occur within 2~3 years after surgery.

2. The follow-up of patients during reexamination should include detailed medical history, pelvic examination, vaginal cytology, chest X-ray, abdominal and pelvic ultrasound, serum CA125 test, etc. CT and MRI examinations can be performed when necessary. Gynecological examination is the most important. Generally, follow-up is conducted every 3 months within 2 to 3 years after surgery, every 6 months after 3 years, and once a year after 5 years. Lifelong follow-up is required after endometrial cancer.

3. Endometrial cancer can be prevented from daily life. Preventive measures include

① Pay attention to the diagnosis and treatment of vaginal bleeding in postmenopausal women and menstrual disorders in women during the menopausal transition period;

② Correctly master the indications and methods of estrogen application;

③ People with high-risk factors, such as obesity, infertility, delayed menopause, long-term use of estrogen and tamoxifen, should be closely followed up or monitored;

④ Strengthen the monitoring of women with Lynch syndrome. It is recommended to conduct annual gynecological examinations, transvaginal ultrasound and endometrial biopsy after the age of 30 to 35 years. It is even recommended to preventively remove the uterus and bilateral adnexa after completing childbearing.